SCM
SPPI

Shelton Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Shelton Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,511
Closed -$24K – 724
2020
Q1 		$24K Hold
10,511
– – ﹤0.01% 636
2019
Q4 		$38K Hold
10,511
– – ﹤0.01% 829
2019
Q3 		$87K Hold
10,511
– – 0.01% 805
2019
Q2 		$90K Buy
+10,511
New +$94K 0.01% 819

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Shelton Capital Management's SPPI Position: Q2 2020 in Review

Shelton Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2020, closing a stake of 10,511 shares — an estimated $24K sold.

Shelton Capital Management first reported a position in SPPI in Q2 2019 and held it in 4 quarters. The position peaked at $90K in Q2 2019. 158 funds tracked by Wall St. Rank hold SPPI as of Q2 2020.

  • Shelton Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Shelton Capital Management sold 10,511 Spectrum Pharmaceuticals Inc shares in Q2 2020, an estimated $24K.
  • Shelton Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2019 and held it in 4 quarters.
  • Shelton Capital Management's Spectrum Pharmaceuticals Inc position peaked at $90K in Q2 2019.
  • 158 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2020.

Based on Shelton Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.